Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

NCT00002174 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Thalidomide

Sponsor

Louisiana State University Health Sciences Center in New Orleans